NASDAQ · CYPHHealthcarePharmaceuticals

Cypherpunk Technologies financials

$3.22−2.72%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Q1 '26
Mar 31
Q4 '25
Dec 31
Revenue$0.00$0.00$0.00
Gross profit$0.00$0.00$0.00
Gross margin———
Operating income-$4.7M-$4.8M-$5.1M
Net income$39.4M-$77.2M$40.2M
Net margin———
Diluted EPS$0.18$-0.46$0.25
EBITDA-$4.7M-$4.8M-$5.1M
Operating cash flow-$2.7M-$3.4M-$6.6M
Free cash flow-$2.7M-$3.4M-$6.6M
Diluted shares217.3M168.1M158.5M

Balance sheet

Period endJun 30Mar 31Dec 31
Cash & equivalents$7.6M$6.7M$14.0M
Short-term investments$0.00$0.00$0.00
Total debt$0.00$0.00$0.00
Total assets$143.0M$87.4M$163.2M
Total liabilities$3.6M$3.0M$9.7M
Shareholders' equity$139.3M$84.4M$153.5M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology